Joseph M. Connors, MD: Optimizing Therapy, Minimizing Toxicity in Hodgkin Lymphoma
327 views · Published 18 September 2016 · 6:56 · Indexed 10 November 2026
Channel: American Society of Hematology · 2016 · Nonprofits & Activism
With improved diagnostics and new therapies, patients with Hodgkin lymphoma have experienced long-term cure rates, but there is still a need to minimize long-term toxicities. Joseph M. Connors, MD, discusses optimizing therapy for these patients.
More from this channel
-
1:52
Ron Reagan Accepts ASH Award - Stem Cell Research
-
4:25
Sen. Jim Talent's Work on Sickle Cell Disease Legislation
-
3:56
ASH and the Reagans Support Stem Cell Research
-
5:42
The American Society of Hematology Celebrates its 50th Anniversary
-
5:57
David Nathan Receives 2011 Wallace H. Coulter Award for Lifetime Achievement in Hematology
-
5:17
James George Receives 2012 Wallace H. Coulter Award for Lifetime Achievement in Hematology
-
2:21
Congress: Protect NIH funding
-
2:21
Act Now: Tell Congress to Stop Further Cuts to Research Funding